About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The research group in General Surgery aims to develop research activities in the field of Surgery from the most clinical and surgical aspects related to the quality of care to the most basic and translational aspects of etiopathogenesis, pathophysiology and the bases of the diseases included in its different areas of interest, as well as in the therapeutic procedures to address them. It is focused in several topics that include the fields of Abdominal Wall Surgery, biomaterials and bioengineering, Colorectal Surgery and Proctology, General Endocrine, Bariatric and Metabolic Surgery, Esophagogastric Surgery, and Thoracic Surgery. It includes clinical surgeons who make up the care teams of the various clinical lines and includes a basic research laboratory with two researchers with special interest in the study of the extracellular matrix and inflammation and biomaterials and their integration.
Research focus
The thoracic surgery research group is dedicated to provide the finest in clinical care, education and research in this surgery specialty to ultimately improve patients’ outcomes and quality of life. To this aim, technological improvements are combined with experimental and clinical research, with a special interest in lung transplantation
Sub-lines:
Clinical research
Humoral rejection in lung transplantation (Irene Bello Rodríguez, coordinator): To understand humoral forms of rejection in human lung transplantation to eventually develop therapies that extend long-term patients’ survival.
Experimental research
Air leakage prevention (Alberto Jáuregui Abularach, coordinator): To contribute to the design and evaluation of new patches and treatments used as a reinforcement or repair material in thoracic surgery, to eventually reduce lung air leakage and improve clinical outcomes. To this aim a new sheep-based surgically induced experimental model has been developed.
Thoracic sympathetic clipping (Javier Pérez Vélez, coordinator): Development of a swine model to perform clipping, unclipping and extirpation of different segments of the sympathetic chain.
Lung transplantation (Iker López Sánz, coordinator): Development of a rat model to perform lung transplantation for teaching and research purposes.
IP: -
IP: Marc Martí Gallostra Collaborators: - Funding agency: Instituto de Salud Carlos III Funding: 21714 Reference: ICI21/00038 Duration: 04/07/2023 - 03/07/2026
IP: Andreea Ciudin Mihai Collaborators: Cristina Gamez Cenzano, Eduard Rodenas Alesina, Ana Marti Delgado, Fiorella Ximena Palmas Candia, Bruno García del Blanco, Ana Belén Méndez Fernández, Ana Maria Ciscar Bellés, Aleix Olivella San emeterio, Marta Comas Martinez, Alvaro Calabuig Goena, Enzamaría Fidilio Meli, Marco Tomasino Funding agency: Instituto de Salud Carlos III Funding: 165000 Reference: PI23/01209 Duration: 01/01/2024 - 31/12/2026
IP: Elizabeth Pando Rau Collaborators: Laia Blanco Cuso, Nair Sonia Fernandes Montes Funding agency: Instituto de Salud Carlos III Funding: 65000 Reference: PI23/01890 Duration: 01/01/2024 - 31/12/2026
IP: Ibai Los Arcos Bertiz Collaborators: M Teresa Martin Gomez, Yolanda Villena Ortiz, Javier Gomis Rodriguez, Joan Gavaldà Santapau, Judith Sacanell Lacasa, Marta Zapata Ortega, Leire Sanchez Corujo Funding agency: Instituto de Salud Carlos III Funding: 37500 Reference: PI23/01467 Duration: 01/01/2024 - 31/12/2026
PhD student: Borja Villanueva Figueredo, Borja Villanueva Figueredo, Borja Villanueva Figueredo Director/s: Francesc Vallribera Valls, Francesc Vallribera Valls University: Universidad Autònoma de Barcelona Year: 2020
The donation will support a research line focused on understanding the progression of this inflammatory liver disease and improving treatment personalisation.
The document provides a comprehensive evaluation of current knowledge on this type of cancer affecting the bile ducts.
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
